Tudóstér: Muszbek László publikációi

Somodi, L., Horváth, E., Bárdos, H., Baráth, B., Pethő, D., Katona, É., Balla, J., Mutch, N., Muszbek, L.: Cellular FXIII in Human Macrophage-Derived Foam Cells.
Int. J. Mol. Sci. 24 (5), 1-12, 2023.

Somodi, L., Bekéné Debreceni, I., Kis, G., Cozzolino, M., Kappelmayer, J., Antal, M., Panyi, G., Bárdos, H., Mutch, N., Muszbek, L.: Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
J. Thromb. Haemost. 20 (5), 1223-1235, 2022.

Raut, S., Katona, É., Riches-Duit, A., Coxon, C., Muszbek, L., Schroeder, V., Rigsby, P.: An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
J. Thromb. Haemost. 20 (2), 525-531, 2022.

Csaba, B., Fésüs, L., Muszbek, L., Sipka, S.: Kesztyűs Lóránd kórélettan professzor, az 1951-ben függetlenné vált Debreceni Orvostudományi Egyetemnek dékánként első vezetője, majd kétszer (1959-1963, 1967-1973) annak rektora.
Gerundium. 13 (3-4), 22-53, 2022.

Kissné Bogáti, R., Katona, É., Shemirani, A., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, 2022.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203 110-116, 2021.

Plamenova, I., Zolkova, J., Sokol, J., Kolkova, Z., Bereczky, Z., Katona, É., Muszbek, L., Kubisz, P., Staško, J.: Genetic Background of Inherited Factor XIII-A Subunit Deficiency: review of the Literature and Description of Two New Cases.
Semin. Thromb. Hemost. 47 (7), 885-889, 2021.

Bovet, J., Hurják, B., Maistre, E., Katona, É., Pénzes-Daku, K., Muszbek, L.: Autoimmune Factor XIII Deficiency With Unusual Laboratory and Clinical Phenotype.
J. Thromb. Haemost. 18 (6), 1330-1334, 2020.

Hurják, B., Kovács, Z., Döncző, B., Katona, É., Haramura, G., Erdélyi, F., Shemirani, A., Sadeghi, F., Muszbek, L., Guttman, A.: N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence.
J. Thromb. Haemost. 18 (6), 1302-1309, 2020.

Pénzes-Daku, K., Hurják, B., Katona, É., Becs, G., Balla, J., Muszbek, L.: Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Int. J. Mol. Sci. 21 1-15, 2020.

Kattula, S., Bagoly, Z., Tóth, N., Muszbek, L., Wolberg, A.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
J. Thromb. Haemost. 18 (4), 885-894, 2020.

Orosz, A., Csapó, A., Bagoly, Z., Székely, E., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471 27-33, 2019.

Orosz, Z., Bárdos, H., Shemirani, A., Bekéné Debreceni, I., Lassila, R., Riikonen, A., Kremer Hovinga, J., Seiler, T., van Dorland, H., Schroeder, V., Boda, Z., Nemes, L., Früh Eppstein, B., Nagy, B., Facskó, A., Kappelmayer, J., Muszbek, L.: Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Int. J. Mol. Sci. 20 (23), 1-17, 2019.

Bagoly, Z., Muszbek, L.: Factor XIII: what does it look like?.
J. Thromb. Haemost. 17 (5), 714-716, 2019.

Balogh, G., Muszbek, L., Komáromi, I.: First Step of the Transglutaminase Reaction Catalyzed by Activated Factor XIII Subunit A, Hybrid Quantum Chemistry/Molecular Mechanics Calculations.
J. Phys. Chem. B. 123 (18), 3887-3897, 2019.

Muszbek, L., Katona, É., Pénzes-Daku, K.: Antibodies against factor XIII subunits.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 17-21, 2017.

Muszbek, L., Pénzes-Daku, K., Katona, É.: Auto-, and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.
J. Thromb. Haemost. 16 (5), 822-832, 2018.

Balogh, L., Katona, É., Mezei, Z., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

Kovac, M., Mitic, G., Lalic-Cosic, S., Djordjevic, V., Tomic, B., Muszbek, L., Bereczky, Z.: Evaluation of endogenous thrombin potential among patients with antithrombin deficiency.
Thromb. Res. 166 50-53, 2018.

Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

Muszbek, L., Pénzes-Daku, K., Katona, É., Kun, M., Bonnefoy, A., Vezina, Z., Szuber, N., Molnárné Rázsó, K., Bereczky, Z., Kerényi, A., Bécsi, B., Erdődi, F., Rivard, G.: Novel approach to the laboratory diagnosis of antibodies against coagulation factors, with special reference to antifactor XIII antibodies: SE2.4.
Clin. Chem. Lab. Med. 56 (9), 128-129, 2018.

Katona, É., Muszbek, L.: The laboratory diagnosis of inherited FXIII deficiencies and the measurement of FXIII activity and antigen level.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 22-26, 2017.

Selmeczi, A., Gindele, R., Ilonczai, P., Fekete, A., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Kovács, K., Bárdos, H., Ádány, R., Muszbek, L., Bereczky, Z., Boda, Z., Oláh, Z.: Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Thromb. Res. 158 1-7, 2017.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

Gindele, R., Selmeczi, A., Oláh, Z., Ilonczai, P., Pfliegler, G., Marján, E., Nemes, L., Nagy, Á., Losonczy, H., Mitic, G., Kovac, M., Balogh, G., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z., Muszbek, L., Bereczky, Z.: Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center.
Thromb. Res. 160 119-128, 2017.

Kovac, M., Mitic, G., Jesic, M., Djordjevic, V., Muszbek, L., Bereczky, Z.: Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency.
Blood Coagul. Fibrinolysis. 28 (3), 264-266, 2017.

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Somodi, L., Molnár, É., Kovács, B., Miklós, T., Ajzner, É., Muszbek, L.: Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Thromb. Res. 158 93-97, 2017.

Tóth, N., Csanádi, Z., Hajas, O., Kiss, A., Nagy-Baló, E., Kovács, K., Sarkady, F., Muszbek, L., Bereczky, Z., Csiba, L., Bagoly, Z.: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation.
Biomed Res. Int. 2017 1-10, 2017.

Menegatti, M., Palla, R., Boscarino, M., Bucciarelli, P., Muszbek, L., Katona, É., Makris, M., Peyvandi, F.: Minimal factor XIII activity level to prevent major spontaneous bleeds.
J. Thromb. Haemost. 15 1728-1736, 2017.

Kun, M., Szuber, N., Katona, É., Pénzes-Daku, K., Bonnefoy, A., Bécsi, B., Erdődi, F., Rivard, G., Muszbek, L.: Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit: novel approach to the diagnosis and classification of anti-factor XIII antibodies.
Haemophilia. 23 (4), 590-597, 2017.

Pénzes-Daku, K., Vezina, C., Bereczky, Z., Katona, É., Kun, M., Muszbek, L., Rivard, G.: Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy: characterization of the antibody.
Haemophilia. 22 (2), 268-275, 2016.

Muszbek, L., Katona, É.: Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.
Semin. Thromb. Hemost. 42 429-439, 2016.

Gindele, R., Oláh, Z., Ilonczai, P., Speker, M., Udvari, Á., Selmeczi, A., Pfliegler, G., Marján, E., Kovács, B., Boda, Z., Muszbek, L., Bereczky, Z.: Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
J. Thromb. Haemost. 14 (4), 704-715, 2016.

Bagoly, Z., Homoródi, N., Kovács, E., Sarkady, F., Csiba, L., Édes, I., Muszbek, L.: How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.

Pénzes-Daku, K., Molnárné Rázsó, K., Katona, É., Kerényi, A., Kun, M., Muszbek, L.: Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome: characterization of the antibody.
J. Thromb. Haemost. 14 (8), 1517-1520, 2016.

Kovac, M., Mitic, G., Mikovic, Z., Djordjevic, V., Muszbek, L., Bereczky, Z.: Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency.
Thromb. Res. 139 111-113, 2016.

Csomós, K., Kristóf, E., Márkus, B., Csomós, I., Kovács, G., Rotem, O., Hodrea, J., Bagoly, Z., Muszbek, L., Balajthy, Z., Csősz, É., Fésüs, L.: Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps.
Cell Death Dis. 7 (8), e2332, 2016.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148 101-106, 2016.

Homoródi, N., Kovács, E., Leé, S., Katona, É., Shemirani, A., Haramura, G., Balogh, L., Bereczky, Z., Szőke, G., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: The lack of aspirin resistance in patients with coronary artery disease.
J. Transl. Med. 14 (1), 74, 2016.

Mezei, Z., Bereczky, Z., Katona, É., Gindele, R., Balogh, E., Fiatal, S., Balogh, L., Czuriga, I., Ádány, R., Édes, I., Muszbek, L.: Factor XIII B Subunit Polymorphisms and the Risk of Coronary Artery Disease.
Int. J. Mol. Sci. 16 (1), 1143-1159, 2015.

Csanádi, Z., Kiss, A., Tóth, N., Bagoly, Z., Bereczky, Z., Muszbek, L., Csiba, L.: Haemostasis changes and endothelium activation during percutaneous transcatheter isolation of the pulmonary veins in patients with atrial fibrillation.
Can. J. Cardiol. 31 (10), S255, 2015.

Kovács, K., Pataki, I., Bárdos, H., Fekete, A., Pfliegler, G., Haramura, G., Gindele, R., Komáromi, I., Balla, G., Ádány, R., Muszbek, L., Bereczky, Z.: Molecular characterization of p.Asp77Gly and the novel p.Ala163Val and p.Ala163Glu mutations causing protein C deficiency.
Thromb. Res. 135 (4), 718-726, 2015.

Gebhard, J., Laczkovics, C., Posch, F., Ay, C., Reitter-Pfoertner, S., Haslacher, H., Muszbek, L., Wolberg, A., Pabinger, I.: Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.
Ann. Hematol. 94 (8), 1301-1310, 2015.

Árokszállási, A., Kerényi, A., Katona, É., Bereczky, Z., Muszbek, L., Boda, Z., Schlammadinger, Á.: The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency - the first experience.
Haemophilia. 21 (1), e118-e121, 2015.

Bereczky, Z., Kovács, K., Bárdos, H., Pataki, I., Balla, G., Pfliegler, G., Haramura, G., Komáromi, I., Ádány, R., Muszbek, L.: Diagnostic considerations based on the experience of genetic analysis in Protein C deficiency and molecular characterization of different mutations.
Clin. Chem. Lab. Med. 52 (9), eA68-eA69, 2014.

Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods.
Thromb. Res. 133 (5), 811-816, 2014.

Katona, É., Muszbek, L., Devreese, K., Kovács, K., Bereczky, Z., Jonkers, M., Shemirani, A., Mondelaers, V., Ermens, A.: Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Haemophilia. 20 (1), 114-120, 2014.

Katona, É., Pénzes-Daku, K., Csapó, A., Fazakas, F., Udvardy, M., Bagoly, Z., Orosz, Z., Muszbek, L.: Interaction of factor XIII subunits.
Blood. 123 (11), 1757-1763, 2014.

Kovács, B., Pataki, I., Bárdos, H., Pfliegler, G., Komáromi, I., Fekete, A., Haramura, G., Ádány, R., Balla, G., Muszbek, L., Bereczky, Z.: Molecular Characterization of Novel Protein C Mutations (p.Asp77Gly, p.Ala163Val and p.Ala163Glu) Causing Protein C Deficiency.
Thromb. Res. 133 S11-, 2014.

Kovac, M., Mitic, G., Miljic, P., Mikovic, Z., Mandic, V., Djordjevic, V., Radojkovic, D., Bereczky, Z., Muszbek, L.: Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency.
Thromb. Res. 133 (6), 1158-1160, 2014.

Kovács, B., Bereczky, Z., Selmeczi, A., Gindele, R., Oláh, Z., Kerényi, A., Boda, Z., Muszbek, L.: Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
Clin. Chem. Lab. Med. 52 (12), 1797-1806, 2014.

Bagoly, Z., Sarkady, F., Magyar, M., Kappelmayer, J., Pongrácz, E., Csiba, L., Muszbek, L.: Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy.
PLoS One. 8 (7), e69417, 2013.

Tóth, L., Muszbek, L., Komáromi, I.: Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations.
J. Mol. Graph. 40 99-109, 2013.

Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
Thromb. Res. 131 (4), 320-324, 2013.

Bereczky, Z., Fiatal, S., Muszbek, L.: Szív- és érrendszeri betegségek.
In: Népegészségügyi Genomika. Szerk.: Ádány Róza, Sándor Judit, Angela Brand, Medicina, Budapest, 121-143, 2013. ISBN: 9789632263885

Bagoly, Z., Székely, E., Kovács, K., Mezei, Z., Katona, É., Kappelmayer, J., Csiba, L., Muszbek, L.: The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, 2013.

Kovács, B., Bereczky, Z., Oláh, Z., Gindele, R., Kerényi, A., Selmeczi, A., Boda, Z., Muszbek, L.: The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency.
Am. J. Clin. Pathol. 140 (5), 675-679, 2013.

Zsóri, K., Muszbek, L., Csiki, Z., Shemirani, A.: Validation of Reference Genes for the Determination of Platelet Transcript Level in Healthy Individuals and in Patients with the History of Myocardial Infarction.
Int. J. Mol. Sci. 14 (2), 3456-3466, 2013.

Simon, Á., Bagoly, Z., Hevessy, Z., Csáthy, L., Katona, É., Vereb, G., Ujfalusi, A., Szerafin, L., Muszbek, L., Kappelmayer, J.: Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Cytom. Part B. Clin. Cytom. 82B (4), 209-216, 2012.

Bagoly, Z., Koncz, Z., Hársfalvi, J., Muszbek, L.: Factor XIII, clot structure, thrombosis.
Thromb. Res. 129 (3), 382-387, 2012.

Bagoly, Z., Katona, É., Muszbek, L.: Factor XIII and inflammatory cells.
Thromb. Res. 129 (Suppl.2), S77-S81, 2012.

Balogh, E., Bereczky, Z., Katona, É., Kőszegi, Z., Édes, I., Muszbek, L., Czuriga, I.: Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Thromb. Res. 129 (2), 133-138, 2012.

Katona, É., Pénzes-Daku, K., Molnár, É., Muszbek, L.: Measurement of factor XIII activity in plasma.
Clin. Chem. Lab. Med. 50 (7), 1191-1202, 2012.

Koncz, Z., Bagoly, Z., Haramura, G., Mezei, Z., Muszbek, L.: Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.
Thromb. Res. 129 (4), 508-513, 2012.

Koncz, Z., Bagoly, Z., Haramura, G., Mezei, Z., Muszbek, L.: Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of alfa2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
Thromb. Res. 130 (3), 528-534, 2012.

Bereczky, Z., Muszbek, L.: A klinikai kutatások tervezése és kivitelezése: elméleti és módszertani alapok.
Medicina, Budapest, 216 p., 2011.

Muszbek, L.: A klinikai tanulmányok típusai és jellegzetességei; deszkriptív és analitikus obszervációs tanulmányok.
In: A klinikai kutatások tervezése és kivitelezése: elméleti és módszertani alapok. Szerk.: Bereczky Zsuzsanna, Medicina Könyvkiadó Zrt., Budapest, 23-44, 2011.

Muszbek, L., Bereczky, Z.: A megfigyelésen alapuló (obszervációs) tanulmányok és közlésük javítására irányuló törekvések.
In: A klinikai kutatások tervezése és kivitelezése: elméleti és módszertani alapok. Szerk.: Bereczky Zsuzsanna, Muszbek László, Medicina Könyvkiadó Zrt., Budapest, 37-44, 2011.

Kohler, H., Ichinose, A., Seitz, R., Ariens, R., Muszbek, L., The Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH: Diagnosis and classification of factor XIII deficiencies.
J. Thromb. Haemost. 9 (7), 1404-1406, 2011.

Muszbek, L., Bereczky, Z., Bagoly, Z., Komáromi, I., Katona, É.: Factor XIII: a Coagulation Factor With Multiple Plasmatic and Cellular Functions.
Physiol. Rev. 91 (3), 931-972, 2011.

Komáromi, I., Bagoly, Z., Muszbek, L.: Factor XIII: novel structural and functional aspects.
J. Thromb. Haemost. 9 (1), 9-20, 2011.

Bereczky, Z., Muszbek, L.: Factor XIII and venous thromboembolism.
Semin. Thromb. Hemost. 37 (3), 305-314, 2011.

Orosz, Z., Katona, É., Facskó, A., Módis, L., Muszbek, L., Berta, A.: Factor XIII subunits in human tears: their highly elevated levels following penetrating keratoplasty.
Clin. Chim. Acta. 412 (3-4), 271-276, 2011.

Muszbek, L., Bagoly, Z., Cairo, A., Peyvandi, F.: Novel aspects of factor XIII deficiency.
Curr. Opin. Hematol. 18 (5), 366-372, 2011.

Orosz, Z., Katona, É., Facskó, A., Berta, A., Muszbek, L.: A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.
J. Immunol. Methods. 353 (1-2), 87-92, 2010.

Muszbek, L., Bereczky, Z., Kovács, B., Komáromi, I.: Antithrombin deficiency and its laboratory diagnosis.
Clin. Chem. Lab. Med. 48 (Suppl.1), S67-S78, 2010.

Veres, K., Szodoray, P., Szekanecz, Z., Lakos, G., Kiss, E., Laczik, R., Sipka, S., Bodolay, E., Zeher, M., Muszbek, L., Szegedi, G., Soltész, P.: Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.
Lupus. 19 (13), 1520-1526, 2010.

Muszbek, L., Bereczky, Z., Bagoly, Z., Shemirani, A., Katona, É.: Factor XIII and Atherothrombotic Diseases.
Semin. Thromb. Hemost. 36 (1), 018-033, 2010.

Shemirani, A., Pongrácz, E., Antalfi, B., Ádány, R., Muszbek, L.: Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.
Thromb. Res. 126 (2), 159-162, 2010.

Bereczky, Z., Kovács, K., Muszbek, L.: Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game.
Clin. Chem. Lab. Med. 48 (Suppl.1), S53-S66, 2010.

Bagoly, Z., Fazakas, F., Marosi, A., Török, O., Bereczky, Z., Haramura, G., Tóth, J., Kappelmayer, J., Muszbek, L.: Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin.
Thromb. Res. 125 (5), 427-431, 2010.

Szűcs, G., Ajzner, É., Muszbek, L., Simon, T., Szepesi, K., Fülesdi, B.: Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery.
J. Orthop. Sci. 14 (5), 484-490, 2009.

Szűcs, G., Muszbek, L., Ajzner, É., Simon, T., Szepesi, K., Fülesdi, B.: A tromboembóliás szövődményekre hajlamosító tényezők vizsgálata ortopédiai protézis beültetések esetén.
Anaesthesiol. Intenziv Ther. 39 (1), 17-23, 2009.

Nagy, B., Simon, Z., Bagoly, Z., Muszbek, L., Kappelmayer, J.: Binding of plasma factor XIII to thrombin-receptor activated human platelets.
Thromb. Haemost. 102 (1), 83-89, 2009.

Karimi, M., Bereczky, Z., Cohan, N., Muszbek, L.: Factor XIII Deficiency.
Semin. Thromb. Hemost. 35 (4), 426-438, 2009.

Kovács, K., Tisza, B., Komáromi, I., Muszbek, L., Bereczky, Z.: Inherited factor V deficiency associated with a novel heterozygous missense mutation (p.G493R) in a patient with excessive surgical bleeding.
Thromb. Haemost. 102 (4), 787-789, 2009.

Pénzes-Daku, K., Kövér, K., Fazakas, F., Haramura, G., Muszbek, L.: Molecular mechanism of the interaction between activated factor XIII and its glutamine donor peptide substrate.
J. Thromb. Haemost. 7 (4), 627-633, 2009.

Ajzner, É., Schlammadinger, Á., Kerényi, A., Bereczky, Z., Katona, É., Haramura, G., Boda, Z., Muszbek, L.: Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Blood. 113 (3), 723-725, 2009.

Mendelboum Raviv, S., Horváth, A., Aradi, J., Bagoly, Z., Fazakas, F., Batta, Z., Muszbek, L., Hársfalvi, J.: 4-thio-deoxyuridylate modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growrth on subendothelial matrix.
J. Thromb. Haemost. 6 (10), 1764-1771, 2008.

Bagoly, Z., Fazakas, F., Komáromi, I., Haramura, G., Tóth, E., Muszbek, L.: Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Thromb. Haemost. 99 668-674, 2008.

Bereczky, Z., Balogh, E., Katona, É., Czuriga, I., Kárpáti, L., Shemirani, A., Édes, I., Muszbek, L.: Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Thromb. Res. 121 (4), 469-476, 2008.

Shemirani, A., Szomják, E., Csiki, Z., Katona, É., Bereczky, Z., Muszbek, L.: Elevated factor XIII level and the risk of peripheral artery disease.
Haematologica. 93 (9), 1430-1432, 2008.

Kerekes, G., Szekanecz, Z., Dér, H., Sándor, Z., Lakos, G., Muszbek, L., Csípő, I., Sipka, S., Seres, I., Paragh, G., Kappelmayer, J., Szomják, E., Veres, K., Szegedi, G., Shoenfeld, Y., Soltész, P.: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
J. Rheumatol. 35 (3), 398-406, 2008.

Bereczky, Z., Bárdos, H., Komáromi, I., Kiss, C., Haramura, G., Ajzner, É., Ádány, R., Muszbek, L.: Factor X Debrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency.
Haematologica. 93 (2), 299-302, 2008.

Herman, K., Vaszily, M., Szentgyörgyi, L., Ajzner, É., Muszbek, L., Péterffy, Á.: Hirudinnal végzett alvadásgátlás heparin kiváltotta thrombocytopeniában harmadik szívműtét során.
Magyar Seb. 61 (Suppl.), 67-70, 2008.

Muszbek, L., Bagoly, Z., Bereczky, Z., Katona, É.: The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
Cardiovasc. Hematol. Agents. Med. Chem. 6 190-205, 2008.

Raut, S., Merton, R., Rigsby, P., Seitz, R., Ariens, R., Barrowcliffe, T., Ichinose, A., Muszbek, L., ISTH/SSC Factor XIII Subcommittee and the Factor XIII Standardization Working Party: A collaborative study to establish the 1st International Standard for factor XIII plasma.
J. Thromb. Haemost. 5 (9), 1923-1929, 2007.

Tóth, T., Deák, L., Zheng, J., Sziklai, I., Fazakas, F., Muszbek, L.: A new mutation in the human pres gene and its effect on prestin function.
Int. J. Mol. Med. 20 (4), 545-550, 2007.

Schlammadinger, Á., Tóth, J., Nagy, B., Fazakas, F., Hársfalvi, J., Kappelmayer, J., Muszbek, L., Radványi, G., Boda, Z.: Bernard-Soulier szindróma: a herediter thrombocytopéniák ritka oka.
Hematol. Transzf. 40 40-46, 2007.

Tóth, T., Kupka, Z., Haack, B., Blin, N., Pfister, M., Sziklai, I., Fazakas, F., Muszbek, L.: Coincidence of mutations in different connexin genes in Hungarian patients.
Int. J. Mol. Med. 20 (3), 315-321, 2007.

Bagoly, Z., Haramura, G., Muszbek, L.: Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
Thromb Haemost. 98 (2), 359-367, 2007.

Bereczky, Z., Balogh, E., Katona, É., Kárpáti, L., Czuriga, I., Édes, I., Muszbek, L.: Elevated factor XIII level and the risk of myocardial infarction in women.
Haematologica. 92 (2), 287-288, 2007.

Muszbek, L., Ariens, R., Ichinose, A.: Factor XIII: recommended terms and abbreviations.
J. Thromb. Haemost. 5 (1), 181-183, 2007.

Vokó, Z., Bereczky, Z., Katona, É., Ádány, R., Muszbek, L.: Factor XIII Val34Leu variant protects against coronary artery disease: a meta-analysis.
Thromb. Haemost. 97 (3), 458-463, 2007.

Muszbek, L., Bagoly, Z.: Fibrin formation disorders and pregnancy loss.
Thromb. Res. Suppl. 119 (Suppl.), S69-S70, 2007.

Ivaskevicius, V., Seitz, R., Kohler, H., Schroeder, V., Ariens, R., Seifried, E., Oldenburg, J., Muszbek, L.: International registry on factor XIII deficiency: basis formed by mostly European data.
Thromb. Haemost. 97 (6), 914-921, 2007.

Bereczky, Z., Balogh, E., Katona, É., Pocsai, Z., Czuriga, I., Széles, G., Kárpáti, L., Ádány, R., Édes, I., Muszbek, L.: Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Thromb. Res. 120 (4), 567-573, 2007.

Losonczy, G., Rosenberg, N., Boda, Z., Vereb, G., Kappelmayer, J., Hauschner, H., Bereczky, Z., Muszbek, L.: Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia.
Haematologica. 92 (5), 698-701, 2007.

Kiss, F., Hevessy, Z., Veszprémi, A., Katona, É., Kiss, C., Vereb, G., Muszbek, L., Kappelmayer, J.: Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Thromb. Haemost. 96 (2), 176-182, 2006.

Balogh, E., Czuriga, I., Bereczky, Z., Boda, K., Kőszegi, Z., Kónya, C., Császár, A., Muszbek, L., Édes, I., Ferdinándy, P.: Magasabb homociszteinszint cardiovascularis betegségekben Magyarországon.
Orv. Hetil. 147 (35), 1685-1690, 2006.

Shemirani, A., Haramura, G., Bagoly, Z., Muszbek, L.: The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
Biochim. Biophys. Acta. Proteins Proteom. 1764 (8), 1420-1423, 2006.

Schlammadinger, Á., Vanhoorelbeke, K., László, P., Bereczky, Z., Muszbek, L., Deckmyn, H., Boda, Z.: von Willebrand factor antigen latex immunoassays are affected to a different extent by rheumatoid factor.
Clin. Appl. Thromb. Hemost. 12 (2), 242-243, 2006.

Losonczy, G., Rosenberg, N., Kiss, C., Kappelmayer, J., Vereb, G., Kerényi, A., Balogh, I., Muszbek, L.: A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa.
Thromb. Haemost. 93 (5), 904-909, 2005.

Kappelmayer, J., Simon, Á., Katona, É., Szántó, A., Nagy, L., Kiss, A., Kiss, C., Muszbek, L.: Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias.
Thromb. Haemost. 94 (2), 454-459, 2005.

Katona, É., Nagy, B., Kappelmayer, J., Baktai, G., Kovács, L., Marialigeti, T., Dezső, B., Muszbek, L.: Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation.
J. Thromb. Haemost. 3 (7), 1407-1413, 2005.

Muszbek, L., Katona, É., Bereczky, Z., Balogh, E., Czuriga, I., Kárpáti, L., Édes, I.: Factor XIII levels and factor XIII A subunit VAL34LEU polymorphism in patients with coronary sclerosis and myocardial infarction.
Clin. Chim. Acta. 355 (Suppl), S94-S94, 2005.

Mádi, A., Kárpáti, L., Kovács, A., Muszbek, L., Fésüs, L.: High-throughput scintillation proximity assay for transglutaminase activity measurement.
Anal. Biochem. 343 (2), 256-262, 2005.

Inbal, A., Lubetsky, A., Krapp, T., Castel, D., Shaish, A., Dickneitte, G., Módis, L., Muszbek, L., Inbal, A.: Impaired wound healing in factor XIII deficient mice.
Thromb Haemost. 94 (2), 432-437, 2005.

Fazakas, F., Nagy, E., Hevessy, Z., Muszbek, L.: Molecular Analysis of Beta-thalassemia in Hungarian Patients.
Clin. Chim. Acta. 355 (Suppl.), S168, 2005.

Kerényi, A., Soltész, P., Veres, K., Szegedi, G., Muszbek, L.: Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction.
Thromb. Res. 116 (2), 139-144, 2005.

Bereczky, Z., Kiss, C., Szabó, T., Bárdos, H., Ajzner, É., Balogh, I., Komáromi, I., Ádány, R., Muszbek, L.: Three novel missense mutations and their functional consequences in two severe inherited factor X deficiencies.
Clin. Chim. Acta. 355 (Suppl1), S310-S311, 2005.

Berczi, C., Tóth, G., Flaskó, T., Muszbek, L., Nemes, Z., Tóth, C.: A prostata specifikus antigén és a biopszia Gleason értékének jelentősége a prostatarák helyi kiterjedtségének megelőzésében.
Magyar Urol. 16 137-142, 2004.

Tóth, T., Kupka, Z., Haack, B., Riemann, K., Braun, S., Fazakas, F., Zenner, H., Muszbek, L., Blin, N., Pfister, M., Sziklai, I.: GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary.
Hum. Mutat. 23 (6), 631-632, 2004.

Kiss, E., Fazekas, B., Tarr, T., Muszbek, L., Zeher, M., Szegedi, G.: Lipidprofil vizsgálata szisztémás lupus erythematosusos betegekben, különös tekintettel a lipoprotein(a) jelentőségére lupusnephritisben.
Orv. Hetil. 145 (5), 217-222, 2004.

Peyvandi, F., Tagliabue, L., Menegatti, M., Karimi, M., Komáromi, I., Katona, É., Muszbek, L., Mannucci, P.: Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency.
Hum. Mutat. 23 (1), 98-107, 2004.

Inbal, A., Muszbek, L., Lubetsky, A., Katona, É., Levi, I., Kárpáti, L., Nagler, A.: Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
Blood Coagul. Fibrinolysis. 15 (3), 249-253, 2004.

Sárváry, A., Szűcs, S., Balogh, I., Becsky, Á., Bárdos, H., Kávai, M., Seligsohn, U., Egbring, R., Lopaciuk, S., Muszbek, L., Ádány, R.: Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.
Cell. Immunol. 228 (2), 81-90, 2004.

Ajzner, É., Muszbek, L.: Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: a rebuttal.
J. Thromb. Haemost. 2 (11), 2075-2077, 2004.

Shemirani, A., Muszbek, L.: Rapid detection of the factor XIII Val34Leu (163 G-->T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis.
Clin. Chem. Lab. Med. 42 (8), 877-879, 2004.

Ajzner, É., Balogh, I., Haramura, G., Boda, Z., Kalmár, K., Pfliegler, G., Dahlbäck, B., Muszbek, L.: Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
J. Thromb. Haemost. 1 (5), 943-949, 2003.

Muszbek, L., Bereczky, Z., Katona, É.: Blood coagulation factor XIII: involvement in fibrinolysis and thrombosis.
In: Thrombosis : fundamental and clinical aspects. Ed.: by J. Arnout [et al.], Leuven University Press, Leuven, Belgium, 197-224, 2003. ISBN: 9058673359

Inbal, A., Muszbek, L.: Coagulation Factor Deficiencies and Pregnancy Loss.
Semin. Thromb. Hemost. 29 (2), 171-174, 2003.

Soltész, P., Veres, K., Lakos, G., Kiss, E., Muszbek, L., Szegedi, G.: Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.
Lupus. 12 (4), 302-307, 2003.

Bereczky, Z., Katona, É., Muszbek, L.: Fibrin stabilization (factor XIII), fibrin structure and thrombosis.
Pathophysiol. Haemost. Thromb. 33 (5-6), 430-437, 2003.

Kárpáti, I., Balla, J., Szőke, G., Bereczky, Z., Páll, D., Ben, T., Toma, K., Katona, E., Mohácsi, A., Paragh, G., Varga, Z., Kakuk, G., Muszbek, L.: A hyperhomocysteinaemia gyakorisága, folsavpótlásban részesülő hemodializált betegekben.
Orv. Hetil. 143 (27), 1635-1640, 2002.

Sárvári, M., Kárpáti, L., Fésüs, L., Deli, L., Muszbek, L., Nemes, Z.: Competitive enzyme-linked immonosorbent assay for N[epszilon]([gamma]-glutamyl)lysine.
Anal. Biochem. 311 (2), 187-190, 2002.

Ajzner, É., Balogh, I., Szabó, T., Marosi, A., Haramura, G., Muszbek, L.: Severe coagulation factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene.
Blood. 99 (2), 702-705, 2002.

Soltész, P., Kerényi, A., Veres, K., Szomják, E., Végh, J., Tizedes, F., Muszbek, L.: Thrombocyta funkció monitorozása akut myocardialis infarctus thrombolyticus kezelése alatt.
Cardiol. Hung. 31 217-224, 2002.

Ambrus, A., Bányai, I., Weiss, M., Hilgenfeld, R., Keresztessy, Z., Muszbek, L., Fésüs, L.: Calcium Binding of Transglutaminases: A43 Ca NMR Study Combined with Surface Polarity Analysis.
J. Biomol. Struct. Dyn. 19 (1), 59-74, 2001.

Katona, É., Ajzner, É., Tóth, K., Kárpáti, L., Muszbek, L.: Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.
J. Immunol. Methods. 258 (1-2), 127-135, 2001.

Kárpáti, I., Balla, J., Újhelyi, L., Ben, T., Mátyus, J., Varga, Z., Muszbek, L., Kakuk, G.: Hyperhomocystaemia in folic acid supplemented haemodialysis patients and polymorhism of methylen-tetrahydrofolate reductase enzyme.
Nephrol. Dial. Transplant. 16 A111, 2001.

Soltész, P., Horváth, A., Veres, K., Gyimesi, E., Muszbek, L., Szegedi, G.: Lupus antikoaguláns és kardiolipin ellenes antitestek szupprimálása nagydózisú intravénás immunglobulinnal.
Allerg. Klin. Immun. 4 (3), 74-78, 2001.

Mátyus, L., Bene, L., Hársfalvi, J., Alvarez, M., Gonzalez-Rodriguez, J., Jenei, A., Muszbek, L., Damjanovich, S.: Organization of the glycoprotein (GP) IIb/IIIa heterodimer on resting human platelets studied by flow cytometric energy transfer.
J. Photochem. Photobiol. B. 65 (1), 47-58, 2001.

Hevessy, Z., Patthy, A., Kárpáti, L., Muszbek, L.: [Alpha](2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
Thromb. Res. 99 (4), 399-406, 2000.

Ajzner, É., Kerényi, A., Szakony, S., Muszbek, L.: A lupus antikoaguláns laboratóriumi diagnosztikája.
Klin. Kísérl. Lab. Med. 27 (4), 170-180, 2000.

Kárpáti, L., Penke, B., Katona, É., Balogh, I., Vámosi, G., Muszbek, L.: A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
Clin. Chem. 46 (12), 1946-1955, 2000.

Schlammadinger, Á., Kerényi, A., Muszbek, L., Boda, Z.: A nagy nyíróerejű áramlási viszonyokat vizsgáló módszerek szerepe a von Willebrand-betegség szűrésében és diagnosztikájában.
Orv. Hetil. 141 (41), 2245-2250, 2000.

Bodolay, E., Lakos, G., Kiss, E., Végh, J., Soltész, P., Muszbek, L., Szegedi, G.: Antipfoszfolipid antitestek kevert kötőszöveti betegségben.
Allerg. Klin. Immun. 3 (3), 54-58, 2000.

Katona, É., Haramura, G., Kárpáti, L., Fachet, J., Muszbek, L.: A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
Thromb. Haemost. 83 268-73, 2000.

Soltész, P., Veres, K., Kiss, E., Lakos, G., Sonkoly, I., Muszbek, L., Szegedi, G.: Az antifoszfolipid-szindróma klinikai és laboratóriumi jellemzőinek összehasonlító vizsgálata = Clinical and laboratory characteristics of antiphospholipid antibody syndrome.
Orv. Hetil. 141 (52), 2821-2825, 2000.

Schlammadinger, Á., Kerényi, A., Muszbek, L., Boda, Z.: Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Thromb. Haemost. 84 (1), 88-92, 2000.

Wartiovaara, U., Mikkola, H., Szőke, G., Haramura, G., Kárpáti, L., Balogh, I., Lassila, R., Muszbek, L., Palotie, A.: Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.
Thromb. Haemost. 84 (4), 595-600, 2000.

Balogh, I., Szőke, G., Kárpáti, L., Wartiovaara, U., Katona, É., Komáromi, I., Haramura, G., Pfliegler, G., Mikkola, H., Muszbek, L.: Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
Blood. 96 (7), 2479-2486, 2000.

Muszbek, L., Yee, V., Hevessy, Z.: Blood coagulation factor XIII: structure and function.
Thromb. Res. 94 (5), 271-305, 1999.

Kerényi, A., Schlammadinger, Á., Ajzner, É., Szegedi, I., Kiss, C., Pap, Z., Boda, Z., Muszbek, L.: Comparison of PFA-100 closure time and template bleeding time in patients with inherited disorders causing defective platelet function.
Thromb. Res. 96 (6), 487-492, 1999.

Balogh, I., Póka, R., Losonczy, G., Muszbek, L.: High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
Thromb. Haemost. 82 (5), 1555-1556, 1999.

Balogh, I., Póka, R., Pfliegler, G., Dékány, M., Boda, Z., Muszbek, L.: High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary.
Thromb. Haemost. 81 (4), 660-661, 1999.

Szőke, G., Bereczky, Z., Balogh, I., Muszbek, L.: Homocisztein anyagcsere laboratóriumi vizsgálata és klinikai jelentősége a thrombosis hajlam megítélése szempontjából: I. Homocisztein metabolizmus és a plazma homocisztein szintjének a meghatározása.
Klin. Kísérl. Lab. Med. 26 (1), 8-14, 1999.

Bereczky, Z., Balogh, I., Szőke, G., Muszbek, L.: Homocisztein anyagcsere laboratóriumi vizsgálata és klinikai jelentősége a thrombosis hajlam megítélése szempontjából: II. Öröklött és szerzett hyperhomocysteinaemiák.
Klin. Kís. Lab. Med. 26 (2), 54-63, 1999.

Szakony, S., Balogh, I., Muszbek, L.: The frequency of haemochromatosis C282Y mutation in the ethnic Hungarian and Romany populations of Eastern Hungary.
Br. J. Haematol. 107 (2), 464-465, 1999.

Újhelyi, L., Balla, G., Muszbek, L., Kakuk, G., Jeney, V., Jacob, H., Vercellotti, G., Balla, J.: Új klinikai kémiai módszer a low-density lipoprotein oxidativ rezisztenciájának mérésére: alkalmazása hemodializált, végstádiumú veseelégtelenségben szenvedő betegeknél.
Magyar Belorv. Arch. 52 (3), 243-247, 1999.

Kerényi, A., Szegedi, I., Sarudi, S., Kappelmayer, J., Kiss, C., Muszbek, L.: A Glanzmann thrombasthenia II. típusa: esetleírás.
Klin. Kísérl. Lab. Med. 25 (4), 162-168, 1998.

Újhelyi, L., Balla, J., Muszbek, L., Kakuk, G., Belcher, J., Jacob, H., Vercellotti, G., Balla, G.: A Microassay to assess the oxidative resistance of low-density lipoproteins.
Clin. Chem. 44 (8), 1762-1764, 1998.

Kappelmayer, J., Katona, É., Muszbek, L.: Flow Cytometric Identification of Platelet And Monocyte Factor XIII by Novel Monoclonal Antibodies.
Br. J. Haematol. 102 (1), 138-138, 1998.

Regéczy, N., Kiss, E., Balogh, I., Kappelmayer, J., Muszbek, L., Szegedi, G.: Öröklött és szerzett thrombophilia együttes előfordulása systemás lupus erythematosusban szenvedő betegben: esetismertetés.
Magyar Reumatol. 39 (2), 105-108, 1998.

Majoros, J., Kappelmayer, J., Kiss, A., Kiss, C., Kiss, M., Jakó, J., Muszbek, L.: Áramlási citometria alkalmazása kevert fenotípusú leukémiák diagnosztikájában.
Klin. Kísérl. Lab. Med. 24 (1), 20-26, 1997.

Van, C., Muszbek, L., Laposata, M.: Fatty acid acylation of platelet proteins.
Prostaglandins Leukot. Essent. Fatty Acids. 57 (1), 33-37, 1997.

Kappelmayer, J., Ajzner, É., Muszbek, L.: Incompatibility of a recombinant thromboplastin and an APTT reagent on a fully automated coagulation analyzer.
Blood Coagul. Fibrinolysis. 8 (4), 251-252, 1997.

Mikkola, H., Muszbek, L., Laiho, E., Syrjälä, M., Hämäläinen, E., Haramura, G., Salmi, T., Peltonen, L., Palotie, A.: Molecular Mechanism of a Mild Phenotype in Coagulation Factor XIII (FXIII) Deficiency: a Splicing Mutation Permitting Partial Correct Splicing of FXIII A-Subunit mRNA.
Blood. 89 (4), 1279-1287, 1997.

Muszbek, L., Rácz, É., Laposata, M.: Posttranslational modification of proteins with fatty acids in platelets.
Prostaglandins Leukot. Essent. Fatty Acids. 57 (4-5), 359-366, 1997.

Pap, Z., Ajzner, É., Kiss, C., Emődy, J., Závodszky, I., Horváth, A., Muszbek, L.: Thrombocytafunkció-zavar albínó gyermekekben.
Orv. Hetil. 137 (8), 467-471, 1997.

Ajzner, É., Aradi, J., Dux, L., Fésüs, L., Fischer, J., Muszbek, L., Punyiczki, M., Sándor, A., Sümegi, B., Szondy, Z., Tőzsér, J.: Biokémia sillabusz orvostanhallgatóknak.
Nyomdaipari Szolgáltató Kft, Debrecen, 696 p., 1996.

Muszbek, L., Mikkola, H., Ádány, R.: Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
Crit. Rev. Clin. Lab. Sci. 33 (5), 357-421, 1996.

Hevessy, Z., Haramura, G., Boda, Z., Udvardy, M., Muszbek, L.: Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Thromb. Haemost. 75 (1), 161-167, 1996.

Laposata, M., Muszbek, L.: Thioesterification of platelet proteins with saturated and polyunsaturated fatty acids.
Lipids. 31 (1), S217-S221, 1996.

Ádány, R., Muszbek, L.: Intratumoral fibrin formation.
In: Tumor Matrix Biology. Ed.: Ádány Róza, CRC Press, Boca Raton, Florida, 205-214, 1995. ISBN: 084934882X

Hidasi, V., Muszbek, L., Ádány, R.: Localization of Transglutaminase in Human Lenses.
J. Histochem. Cytochem. 43 (11), 1173-1177, 1995.

Hidasi, V., Muszbek, L.: Transglutaminase activity in normal human lenses and in senile cataract.
Ann. Clin. Lab. Sci. 25 (3), 236-240, 1995.

Hallak, H., Muszbek, L., Laposata, M., Belmonte, E., Brass, L., Manning, D.: Covalent binding of arachidonate to G protein alpha subunits of human platelets.
J. Biol. Chem. 269 (7), 4713-4716, 1994.

Soltész, P., Zeher, M., Muszbek, L., Szegedi, G.: Lupus anticoagulans és szerzett thrombocyta "storage pool" megbetegedés egyidejű előfordulása.
Orv. Hetil. 135 (19), 1031-1034, 1994.

Muszbek, L., Laposata, M.: Covalent modification of proteins by arachidonate and eicosapentaenoate in platelets.
J. Biol. Chem. 268 (24), 18243-18248, 1993.

Ádány, R., Fodor, F., Molnár, P., Ablin, R., Muszbek, L.: Increased density of histiocytes containing factor XIIIa in uterine leiomyomas.
In: Proceedings of the Second International Conference on Factor XIII.. Eds.: McDonagh, J., Seitz, R., Egbring R, Schattauer, Stuttgart, 53-57, 1993.

Muszbek, L., Laposata, M.: Myristoylation of proteins in platelets occurs predominantly through thioester linkages.
J. Biol. Chem. 268 (11), 8251-8255, 1993.

Kappelmayer, J., Haramura, G., Muszbek, L.: Nefelometriás elven működő automata koagulométerrel (IL ACL 300) történő fibrinogén meghatározás során szerzett tapasztalataink.
Lab. Diagn. 2 105-108, 1993.

Muszbek, L., Polgár, J., Boda, Z.: Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
Thromb. Haemost. 69 (3), 282-285, 1993.

Fujimoto, T., Stroud, E., Whatley, R., Prescott, S., Muszbek, L., Laposata, M., McEver, R.: P-selectin is acylated with palmitic acid and stearic acid at cysteine 766 through a thioester linkage.
J. Biol. Chem. 268 (15), 11394-11400, 1993.

Kávai, M., Ádány, R., Pásti, G., Surányi, P., Szűcs, G., Muszbek, L., Boján, F., Szegedi, G.: Marker profile, enzyme activity, and function of a human myelomonocytic leukemia cell line.
Cell. Immunol. 139 (2), 531-540, 1992.

Horváth, A., Muszbek, L., Kellie, S.: Translocation of pp60c-src to the cytoskeleton during platelet aggregation..
Embo J. 11 (3), 855-861, 1992.

Szabó, E., Muszbek, L.: Isolation and partial characterization of a cystine-rich basic heparin-binding protein from bovine platelets.
Biochem. Biophys. Res. Commun. 174 (1), 70-76, 1991.

Ádány, R., Fodor, F., Molnár, P., Ablin, R., Muszbek, L.: Increased density of histiocytes in uterine leiomyomas.
Int. J. Gynecol. Pathol. 9 (2), 137-144, 1990.

Polgár, J., Hidasi, V., Muszbek, L.: Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).
Biochem. J. 267 (2), 557-560, 1990.

Polgár, K., Ádány, R., Ábel, G., Kappelmayer, J., Muszbek, L., Papp, Z.: Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescence and phagocytosis assays.
Am. J. Hum. Genet. 45 (5), 786-792, 1989.

Boda, Z., Pfliegler, G., Muszbek, L., Tóth, A., Ádány, R., Hársfalvi, J., Papp, Z., Tornai, I., Rák, K.: Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy: a case report.
Haemostasis. 19 348-352, 1989.

Muszbek, L., Laposata, M.: Covalent modification of platelet proteins by palmitate.
Blood. 74 1339-1347, 1989.

Boján, F., Kávai, M., Ádány, R., Pásti, G., Nemes, Z., Sipos, A., Takács, I., Ács, G., Szűcs, G., Muszbek, L., Szegedi, G.: Establishment of a new human myelomonocytic leukaemia cell line (DD) and its functional activation by 12-0-tetradecanoylphorbol 13-acetate (TPA) and lipopolysaccharide (LPS).
Cytotechnology. 5 (Suppl.), 31, 1989.

Ádány, R., Kappelmayer, J., Berényi, E., Szegedi, A., Fábián, E., Muszbek, L.: Factors of the extrinsic pathway of blood coagulation in tumour associated macrophages.
Thromb. Haemost. 62 (3), 850-855, 1989.

Soltész, P., Sipos, A., Sonkoly, I., Muszbek, L., Horváth, A., Szegedi, G.: Foszfolipid ellenes autoantitestek előfordulása szisztémás lupus erythematosusban.
Magyar Belorv. Arch. 42 (3), 97-103, 1989.

Muszbek, L., Laposata, M.: Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages.
J. Biol. Chem. 264 9716-9719, 1989.

Ádány, R., Muszbek, L.: Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus.
Histochemistry. 91 (2), 169-174, 1989.

Ádány, R., Kiss, A., Kappelmayer, J., Muszbek, L.: A véralvadás XIII-as faktora a monocyta/macrophages sejtvonalban.
Lab. Diagn. 15 91-95, 1988.

Ádány, R., Glukhova, M., Kabakov, A., Muszbek, L.: Characterisation of connective tissue cells containing factor XIII subunit a.
J. Clin. Pathol. 41 (1), 49-56, 1988.

Horváth, A., Frendl, G., Muszbek, L., Soltész, P.: Citrátos vér aktivált parciális tromboplasztin idő: új automatizált teszt a heparin kezelés monitorozására.
Lab. Diagn. 15 207-219, 1988.

Ádány, R., Szegedi, A., Ablin, R., Muszbek, L.: Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease.
Thromb. Haemost. 60 (2), 293-297, 1988.

Boda, Z., Muszbek, L., Hársfalvi, J., Tóth, A., Pfliegler, G., Tornai, I., Rák, K.: FXIII (fibrin stabilizáló faktor, Laki-Lóránd-faktor)-hiány esete.
Orv. Hetil. 129 (41), 2199-2202, 1988.

Sonkoly, I., Soltész, P., Muszbek, L., Szegedi, G.: Lupus anticoagulans szűrővizsgálatok SLE-s betgek körében.
Magyar Belorv. Arch. 41 207-219, 1988.

Muszbek, L., Ádány, R., Kávai, M., Boda, Z., Lopaciuk, S.: Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity.
Thromb. Haemost. 59 (2), 231-235, 1988.

Asijee, G., Muszbek, L., Kappelmayer, J., Polgár, J., Horváth, A., Sturk, A.: Platelet vinculin: a substrate of activated factor XIII.
Biochim. Biophys. Acta Prot. Struct. Mol. Enzym. 954 303-308, 1988.

Asyee, G., Sturk, A., Muszbek, L.: Association of vinculin to the platelet cytoskeleton during thrombin-induced aggregation.
Exp. Cell Res. 168 (2), 358-364, 1987.

Ádány, R., Muszbek, L.: Cells containing Factor XIII subunit a in benign and soft tissue tumours.
Histopathology. 11 (12), 1341-1343, 1987.

Ádány, R., Nemes, Z., Muszbek, L.: Characterization of factor XIII containing-macrophages in lymph nodes with Hodgkin's disease.
Br. J. Cancer 55 (4), 421-426, 1987.

Ádány, R., Kiss, A., Muszbek, L.: Factor XIII: a marker of mono- and megakaryocytopoesis.
Br. J. Haematol. 67 167-172, 1987.

Glukhova, M., Ornatsky, O., Frid, M., Kabakov, A., Muszbek, L., Smirnov, V., Ádány, R.: Identification of smooth muscle-derived foam cells in the atherosclerotic plaque of human aorta with monoclonal antibody IIG10.
Tissue Cell. 19 (5), 657-663, 1987.

Muszbek, L., Glukhova, M., Frid, M., Kabakov, A., Koteliansky, V., Ádány, R.: The identification of vimentin in human blood platelets.
Eur. J. Cell Biol. 43 (3), 501-504, 1987.

Nemes, Z., Thomázy, V., Muszbek, L., Ádány, R.: Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (FXIIIa) in human lymph nodes.
J. Pathol. 149 121-132, 1986.

Polgár, J., Léránt, I., Muszbek, L., Machovich, R.: Thrombomodulin inhibits the activation of factor xiii by thrombin.
Thromb. Res. 43 (5), 585-590, 1986.

Fésüs, L., Metsis, M., Muszbek, L., Koteliansky, V.: Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments.
Eur. J. Biochem. 154 (2), 371-374, 1986.

Török, O., Szabó, M., Fésüs, L., Muszbek, L., Harsányi, Á., Szokol, M., Papp, Z.: Adatok a Duchenne izomdystrophia prenatális diagnosztikájához.
Magyar Nőorv. L. 48 202-205, 1985.

Muszbek, L., Szegedi, G., Polgár, J., Kávai, M., Ádány, R.: Factor XIII of blood coagulation in human monocytes.
Thromb. Res. 37 (3), 401-410, 1985.

Ádány, R., Belkin, A., Vasilevskaya, T., Muszbek, L.: Identification of blood coagulation factor XIII in human peritoneal macrophages.
Eur. J. Cell Biol. 38 (1), 171-173, 1985.

Muszbek, L., Polgár, J., Fésüs, L.: Kinetic determination of blood coagulation Factor XIII in plasma.
Clin. Chem. 31 (1), 35-40, 1985.

Koteliansky, V., Gneushev, G., Glukhova, M., Venyaminov, S., Muszbek, L.: Identification and isolation of vinculin from platelets.
FEBS Lett. 165 (1), 26-30, 1984.

Török, O., Szabó, M., Harsányi, Á., Polgár, K., Muszbek, L., Fésüs, L., Diószeghy, P., Mechler, F., Szokol, M., Papp, Z.: Genetikai tanácsadás Duchenne izomdystrophiában.
Ideggyógyász. Szle. 35 781-784, 1982.

Fésüs, L., Hársfalvi, J., Kovács, E., Muszbek, L., Stadler, I.: Effect of prostaglandin I2 on platelet adhesion.
Biomaterials. 2 (1), 53-54, 1981.

Fésüs, L., Muszbek, L., Laki, K.: The effect of methylglyoxal on actin.
Biochem. Biophys. Res. Commun. 99 (2), 617-622, 1981.

Hársfalvi, J., Muszbek, L., Stadler, I., Fésüs, L.: Inhibition of platelet factor 3 availability by prostacyclin.
Prostaglandins. 20 (5), 935-945, 1980.

Muszbek, L., Hauck, M.: Fragmentation of actin by thrombin-like snake venom proteases.
Biochim. Biophys. Acta. Prot. Struct. 577 (1), 34-43, 1979.

Muszbek, L., Szabó, T., Fésüs, L.: A highly sensitive method for the measurement of ATPase activity.
Anal. Biochem. 77 (1), 286-288, 1977.

Fésüs, L., Csaba, B., Muszbek, L.: Platelet activating factor, the trigger of haemostatic alterations in rat anaphylaxis.
Clin. Exp. Immunol. 27 (3), 512-515, 1977.

Muszbek, L., Fésüs, L., Szabó, T., Hársfalvi, J.: Procoagulant activity of thrombosthenin preparations.
Thromb. Res. 10 (5), 635-644, 1977.

Muszbek, L., Kuznicki, J., Szabó, T., Drabikowski, W.: Troponin C like protein of blood platelets.
FEBS Lett. 80 (2), 308-312, 1977.

Fésüs, L., Csaba, B., Muszbek, L.: Activation and consumption of Hageman factor in the anaphylactic shock of the rat.
Int. Arch. Allergy Appl. Immunol. 51 (4), 496-507, 1976.

Muszbek, L., Fésüs, L., Ölveti, É., Szabó, T.: Cleavage of Thrombosthenin a by thrombin: evidence for the existence of two types of bovine platelet actin.
Biochim. Biophys. Acta. Prot. Struct. 427 (1), 171-177, 1976.

Fésüs, L., Csaba, B., Muszbek, L.: Platelets in rat anaphylaxis.
Acta Allergol. 31 (2), 85-93, 1976.

Fésüs, L., Muszbek, L.: Reduced aggregability of platelets in rat anaphylaxis.
Haemostasis. 5 (1), 51-56, 1976.

Fésüs, L., Muszbek, L., Csaba, B.: Evidence of fibrinogen degradation in rat anaphylaxis.
Int. Arch. Allergy Appl. Immunol. 49 (4), 540-547, 1975.

Muszbek, L., Gladner, J., Laki, K.: The fragmentation of actin by thrombin. Isolation and characterization of the split products.
Arch. Biochem. Biophys. 167 (1), 99-103, 1975.

Muszbek, L., Laki, K.: Cleavage of Actin by Thrombin.
Proc. Natl. Acad. Sci. U. S. A. 71 (6), 2208-2211, 1974.

Fésüs, L., Ölveti, É., Csaba, B., Muszbek, L.: Fibrinolytic-activity in Rat Anaphylaxis.
Thromb. Diath. Haemorrh. 32 (2-3), 341-349, 1974.

Laki, K., Muszbek, L.: On the interaction of F-actin with fibrin.
Biochim. Biophys. Acta. Prot. Struct. 371 (2), 519-525, 1974.

Csaba, B., Muszbek, L., Szokol, M., Fésüs, L.: Development of anaphylactoid hypersensitivity after adrenocortical failure due to Bordetella pertussis vaccine.
Acta Physiol. Acad. Sci. Hung. 44 (3-4), 1973.

Muszbek, L., Fésüs, L., Csaba, B.: Disturbance of blood glucose regulation in pertussis sensitized rats.
Acta Allergol. 27 (4), 257-263, 1972.